BCA-225 (Cu-18) Mouse Monoclonal Antibody

BCA-225
BCA-225 antibody shows a moderate to strong cytoplasmic staining reaction for breast invasive ductal carcinoma, metastatic to lymph node.

BCA-225 (Cu-18) Mouse Monoclonal Antibody

Specialties: Anatomic Pathology Breast/Gynecological Pathology Cytopathology

Updated: 2017-05-24 08:46:09

Anti-BCA-225 primary antibody labels breast cancer antigen 225 (BCA-225) in primary and metastatic breast carcinoma.  BCA-225 was first identified in T47D breast carcinoma cells, but its expression in other carcinomas such as lung, kidney, ovary and endometrium has also been demonstrated.1-4  BCA-225 expression has also been found in sebaceous gland tumors.5,6

  1. Mesa-Tejada R, et al. Am J Pathol; 1988 130:305-14.
  2. Loy TS, et al. Am J Clin Pathol. 1991; 96:326-9.
  3. Brown RW, et al. Am J Clin Pathol. 1997; 107:12-9.
  4. Ma CK, et al. Am J Clin Pathol. 1993; 99:551-7.
  5. Ansai S, et al. J Dermatol. 1994; 21:20-4.
  6. Sinard, JH. Arch Ophthalmol. 1999; 117:776-83.

Specifications


  • Reactivity: paraffin
  • Visualization: cytoplasmic
  • Control: breast carcinoma
  • Dilution Range: 1:25-1:100*

Package Inserts


IFU SDS

Ordering Information

For in vitro diagnostic (IVD) use in USA

0.1 mL concentrate225M-14
0.5 mL concentrate225M-15
1 mL concentrate225M-16
1 mL predilute225M-17
7 mL predilute225M-18

For in vitro diagnostic (IVD) use in Canada

0.1 mL concentrate225M-14
0.5 mL concentrate225M-15
1 mL concentrate225M-16
1 mL predilute225M-17
7 mL predilute225M-18

For in vitro diagnostic (IVD) use in Europe

0.1 mL concentrate225M-14
0.5 mL concentrate225M-15
1 mL concentrate225M-16
1 mL predilute225M-17
7 mL predilute225M-18

For research use only (RUO) in Japan

0.1 mL concentrate225M-14-RUO
0.5 mL concentrate225M-15-RUO
1 mL concentrate225M-16-RUO
1 mL predilute225M-17-RUO
7 mL predilute225M-18-RUO

 

To request information on this product in additional countries, please click the button below.

Request More Information